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Antagonists for ligand-gated ion channels are often
employed as tools to isolate synaptic activity due to
different neurotransmitters and therefore need to have
high selectivity and high afﬁnity for the target receptor.
However, in some circumstances a low-afﬁnity antagonist
is needed: indeed, it was by using low-afﬁnity competitive
antagonists at NMDA or AMPA receptors that Clements
et al. (1992) and Tong & Jahr (1994) obtained very
robust estimates of the glutamate synaptic concentration
and time course. The method relies on an accurate
kinetic description of the agonist-induced activation of
postsynaptic channels and on the availability of an
antagonistwithatimecourseofunbindingthatissimilarto
thatofneurotransmitterinthecleft(approximately1ms).
In these conditions, the amount of inhibition induced by
theantagonistisinverselyproportionaltothepermanence
and concentration of the agonist in the cleft.
Among the relatively few antagonists for glycine
receptors, the best known, strychnine, is unsuitable for
thisrolebecause,althoughhighlyselectiveandcompetitive
(see the Schild analysis in Kumamoto & Murata, 1996;
Lewis et al. 1998), it has a high afﬁnity (in the nanomolar
range; Saul et al. 1994). A more suitable candidate is
SR-95531 (gabazine), a potent GABAA antagonist that
behaves as a low-afﬁnity competitive antagonist of native
glycine receptors (Wang & Slaughter, 2005). Whether
this antagonist could be useful depends on the actual
value of its unbinding rate. Whereas the equilibrium
dissociation constant (KB) of a competitive antagonist
can be measured by macroscopic methods (i.e. Schild
analysis; Arunlakshana & Schild, 1959), the individual
microscopic rate constants can be estimated only using
fastconcentrationjumpsandonlybypostulatingakinetic
scheme of activation that describes the properties of the
receptors. This is the aim of the present work. By applying
kinetic modelling we have obtained an estimate of the
microscopic rates for binding of SR-95531 at glycine
receptors. These rates have values compatible with our
independent macroscopic KB estimate for the antagonist
and reveal a fast unbinding, occurring at a rate of about
3000s−1,enoughtobecomparablewiththeexpectedtime
course of synaptically released glycine.
Methods
Human embryonic kidney cells (HEK 293) were
maintained in an incubator with 95% air−5% CO2
in Dulbecco’s modiﬁed Eagle’s medium, plated on
glass coverslips and transfected after 10h by a calcium
phosphate–DNA co-precipitation method with cDNAs
coding for the enhanced green ﬂuorescence protein
(EGFP)andfortheratα1andβ glycinereceptorsubunits
ina1:40ratio(Groot-Kormelinketal.2002).Suchahigh
ratio was chosen to minimize the expression of homo-
meric α1 channels (Burzomato et al. 2003). Each dish was
transfected with 3μg DNA and patch-clamp recordings
were made 14–48h after transfection.
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Recordings were performed in the whole-cell or
outside-out patch-clamp conﬁguration; in both cases
the extracellular solution contained (mm): NaCl 102.7,
sodiumgluconate20,KCl2,CaCl22,MgCl21.2,Hepes10,
glucose 14, sucrose 15 and tetraethylammonium chloride
20; pH adjusted to 7.4 with NaOH, and the intracellular
solution contained (mm): KCl 107.1, CaCl2 1, MgCl2 1,
Hepes 10, EGTA 11, tetraethylammonium chloride 20,
MgATP 2; pHadjusted to 7.2 with KOH.
For both conﬁgurations, the cell or the patch was held
at −60mV, without correction for junction potential.
Borosilicate glass capillaries (GC150TF, Clark Electro-
medical, Warner, UK) were pulled to a resistance of
1–2M  (whole cell) or 7–10M  (outside-out patch).
In whole-cell experiments, fast drug application was
achievedbyamodiﬁedU-tubesystemthatallowed1–2ms
solution exchange, measured using the open tip potential
changefollowingapplicationofa30%dilutedextracellular
solution (Burzomato et al. 2003). Series resistance
(3–8M ) was routinely compensated (80–95%). Fast
concentration jumps were performed using a theta tube
(14-072-01, Hilgenberg, Malsfeld, Germany) with the tip
cuttoaﬁnaldiameterofapproximately150μmanddriven
by a piezo-stepper (Burleigh Instruments, NY, USA).
Glycine (Fluka) and SR-95531 (gabazine, Sigma) were
washed in or out through the double-barrelled perfusion
system. The exchange time was measured by application
of a diluted solution both before each experiment (to
optimize the position of the electrode) and after rupture
of the patch. Typical exchange times were approximately
80–100μs (10–90% rise time) and only those patches
in which the exchange time was faster than 150μsw e r e
included in the analysis.
CurrentresponseswererecordedwithanAxopatch200B
ampliﬁer, ﬁltered at 5kHz and digitized using a Digidata
1322Adataacquisitionsystem(samplingrate,25–50kHz)
and Clampex software (all Axon Instruments Inc.).
For the Schild analysis experiments, partial glycine
concentration–response curves in control condition and
in the presence of 100, 300 or 500μm SR-95531 were
ﬁtted simultaneously with power functions with the
constraint of equal slopes (CVFIT program, available
from http://www.ucl.ac.uk/Pharmacology/dcpr95.html).
For each concentration of antagonist, this produced
an estimate of the dose ratio (r; i.e. by how much a
glycine concentration must be increased in the presence
of antagonist in order to obtain the same response as in
control).
ThemeanvaluesofrforeachconcentrationofSR-95531
were plotted on a log–log scale and ﬁtted by the Schild
equation:
r = 1 +
[B]
KB
where [B] is the concentration of SR-95531 and KB is the
dissociation equilibrium constant.
The Schild plot of log(r−1) versus log[B] was initially
ﬁtted with a power function of the form:
r − 1 = a[B]
n
where a is a constant and n is the slope of the Schild
plot which is predicted to be one for a purely competitive
antagonist. As the slope was sufﬁciently close to one, the
data were re-ﬁtted using the Schild equation (i.e. slope
constrained to one) to estimate KB.
For the analysis of outside-out patch experiments,
10–50 individual responses to glycine were averaged. In
most experiments, rundown was apparent only in the
ﬁrst 2–3min of recording, by which time the response
amplitude reached a plateau. Once steady state was
reached, only those experiments in which the difference
between the average of the ﬁrst and last three responses
in a series was less than 5% were included in the
analysis. Glycine pulses were repeated every 10 (short
applications) or 15s (long applications), allowing full
recovery from desensitization between each pulse (Gentet
& Clements, 2002). All rise times (i.e. for agonist
responses and tip potentials) were measured from 10%
to 90% of the peak amplitude. The time course of
desensitization during prolonged pulses of agonist and
that of deactivation following short pulses were ﬁtted
with a mixture of exponentials (usually two). Rate
constants were determined using ChanneLab software
(Synaptosoft Inc.), which optimizes rate constant values
by a simplex algorithm. The quality of the ﬁt was assessed
by calculating the sum of squared differences between the
data points and the ﬁt (divided by the sum of squared
data points and normalized by the number of points;
see Clements & Westbrook, 1994). We used the open
tip potential measured at the end of each experiment
(scaled appropriately) as an input for the concentration
proﬁle. The ﬁtting procedure and the constraints used
are described in the Results. Data are expressed as
means±s.d. of the mean. The coefﬁcient of variation of
the mean (CVM) for rate constants was calculated across
experiments.
Results
The traces in Fig.1 show the ﬁrst two protocols in
our experiments: a saturating concentration of the
agonist glycine (Gly, 3mm) was applied in control
conditions either for 200ms, to determine the kinetics
of desensitization (Fig.1A–C), or for 3ms, to determine
the rate constants for deactivation (i.e. the decay of the
currentonceglycineisremoved,Fig.1D–F).Thiswasdone
because,inordertomeasurethemicroscopicbindingrates
of the glycine receptor antagonist SR-95531, it was ﬁrst
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necessary to deﬁne a kinetic scheme that could describe
glycine responses in control conditions (and to determine
its rates).
Figure1Ashowsaresponse(averageof15applications)
to a 200ms pulse of Gly. The average 10–90% rise time
of the response was 140±20μs( n=5). In this and all
other experiments, the desensitization phase was best
ﬁttedbytwoexponentialcomponentswithtimeconstants
τ1 =12±2 (amplitude 41±11%) and τ2 =104±22ms
(59±11%, n=5). This observation implies that at least
two desensitized states (with different lifetimes) are
required in order to ﬁt the data adequately. Because our
main aim was to determine the binding rates for the
antagonist, we decided to use the simplest possible model
that could describe the response to glycine pulses. This
mechanism (shown in Fig.1G) contains two independent
desensitized states connected to a single fully bound
open state and three binding sites for glycine, as in our
recent analysis of single-channel data at a range of glycine
concentrations (Burzomato et al. 2004). Although there
is no knowledge of how desensitized states are connected,
Figure 1. Kineticschemefortheactivationofheteromericglycinereceptorsbysaturatingconcentrations
of glycine
A, shows the averaged current response of an outside-out patch to a 200 ms application of 3 mM glycine. The
time course of glycine concentration (taken from the open tip potential recorded at the end of the experiment) is
shown at the bottom of the trace in this and the following ﬁgures. B, continuous black line shows the ﬁt to the
data ( ) obtained after optimizing the rate constants in the model shown in G. C, shows the response onset on an
expanded timescale; note the good agreement of the ﬁtted curve (black line) to the experimental inward current.
D, shows the averaged current response to a short (3 ms) application of 3 mM glycine. The deactivation phase was
empirically ﬁtted with two exponentials (see Results). The data were ﬁtted to the model in G with association and
dissociation rate constants (kon and koff, respectively) as free parameters and the desensitization and resensitization
rates ﬁxed to the average values obtained from the ﬁts of 200 ms steps. F, shows the rising phase of the trace and
the ﬁt of E on an expanded timescale (note the different sampling rate of 20 μs, instead of 40 μsa si nC). G, the
scheme was used to ﬁt the data and shows the average of the rate constants ﬁtted to the data from ﬁve patches
(for the 200 ms steps) and six patches (for the 3 ms steps; units are s−1 or s−1 μM−1 as appropriate).
our purpose here was to correct for desensitization rather
than to study it. Glycine heteromeric channels have three
open states (Burzomato et al. 2004), but we have included
only one open state (reached from the fully liganded shut
state),becausethepresentexperimentswereperformedat
saturatingconcentrationsofglycine,andanycontribution
bylowerligandedstatesofthereceptorwouldbenegligible.
The gating rates were ﬁxed to our previously obtained
values (7000 and 130000s−1 for α and β, respectively;
Burzomatoetal.2004).Thisisanapproximation,because
these values were obtained from cell-attached recordings
and with a more detailed mechanism than the one used
here. However, gating rates in the outside-out patch
conﬁguration are not slower (M. Beato, unpublished
data).Heteromericglycinereceptorgatingisthereforevery
fast and would contribute relaxation time constants of
the order of 10–100μs, which could not be resolved in
concentration jump experiments.
Current responses to 200ms jumps were ﬁtted in
two stages. First, the whole average trace was ﬁtted,
from the onset of the application up to the time when
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desensitization reached a steady level (180ms later). This
ﬁt allowed the estimation of the rates for entry and exit
into the desensitized states together with the association
rate constant (kon) for glycine. Gating constants α and β
were ﬁxed to the above values and the dissociation rate
constant (koff)ﬁ x e dt o3 0 0s −1, as in our single-channel
experiments (Burzomato et al. 2004). The rate constants
for binding were constrained to be the same for each
binding step, except for the statistical factors accounting
for the number of available sites. The entry and exit rates
were 50s−1 ±36% (CVM) and 150s−1 ±13% for the
fast desensitized state (A3D1 in Fig.1G) and 8s−1 ±32%
and 14s−1 ±17% (n=5) for the slow desensitized state
(A3D2). Once a satisfactory ﬁt of the time course of
desensitization was obtained for each patch (Fig.1B),
we used these estimates to ﬁx the desensitization rates
(withintheschemeofFig.1G)andre-ﬁttedonlytherising
phase of the response (up to the peak), with kon as the
only free variable. As shown in Fig.1C, this produced a
good ﬁt of the rising phase and the average estimate of
kon was 5.4×106 s−1 μm−1 ±22%, n=5. It is important
to note that the rise time of the response to glycine
(140±20μs) is comparable with that of the solution
exchange (110±10μs on average); as a consequence, our
estimate of kon must be interpreted as a lower limit of its
actual value.
As there is some controversy about the number of
α subunits (the main binding subunit) in heteromeric
glycine receptors (Langosch et al. 1988; Kuhse et al. 1993;
Burzomato et al. 2003; Grudzinska et al. 2005), we have
also tried the same ﬁtting procedure with a model that
includedonlytwobindingsites.Thequalityoftheﬁtswas
only marginally worse than with three binding sites and
thedifferencewasnotstatisticallysigniﬁcant(paired t test
on the normalized sum of squares, see Methods, P =0.2).
Nevertheless, the use of a model with three binding steps,
such as the one in Fig.1G, is justiﬁed by the results of our
own analysis of single-channel experiments (Burzomato
et al. 2004) and by the observation by Grudzinska et al.
(2005) that αβ heteromeric glycine receptors are likely to
contain more than two binding sites for Gly, even if the
pentamer contains only two copies of the α subunit.
In order to determine koff for glycine, we switched
to a protocol of short (3ms) glycine applications (as
shown in Fig.1D, which is the average of 21 responses).
The average rise time of the response was 180±20μs
(n=6)andthatofthesolutionexchangewas130±20μs,
both somewhat slower, but not signiﬁcantly different
from the rise time of the responses to 200ms steps
(140±20μs).Thedeactivationphasewasbestﬁttedwith
two exponential components, with time constants and
amplitude τ1 =9±1ms (51±5%) and τ2 =61±11ms
(49±5%;n=6).Inallﬁts,desensitizationrateswereﬁxed
to the overall average values obtained from the 200ms
step responses. Fits were performed in two stages: ﬁrst the
wholetrace(upto160msafterthepeak)wasﬁttedwithkon
and koff as free parameters (Fig.1E) in order to estimate
koff (237s−1 ±6%, n=6); second, koff was ﬁxed to the
value obtained in each patch and only the rising phase
of the response was ﬁtted with kon as the free parameter
(Fig.1F). The estimate of kon from the short pulses was
2.6×106 s−1 μm−1 ±21%;thisisslowerthantheestimate
obtained from the 200ms step experiments, but the
difference was not signiﬁcant (unpaired t test, P =0.16)
and could be due to the relatively slower exchange time
achieved with short pulses (130 versus 110μs). Therefore
the two sets of estimates were averaged, giving a mean kon
of 4.1×106 s−1 μm−1 ±20% (n=11). The ﬁnal average
values for the rates are shown in the scheme of Fig.1G.
In order to decide the SR-95531 concentration for
subsequent experiments, it was necessary to estimate
its afﬁnity for glycine receptors. Antagonist potency is
commonly reported in the literature as IC50, even though
this value depends on the agonist concentration and
cannot be easily related to antagonist occupancy of the
receptor or to any of the microscopic or macroscopic
binding rates. Because of that, we had to obtain an
experimentalestimateofthebindingequilibriumconstant
(KB) of SR-95531. This was done by Schild analysis, by
recording partial glycine concentration–response curves
in the whole-cell conﬁguration in control solution and in
the continuous presence of 100, 300 or 500μm SR-95531.
ThetracesontheleftofFig.2A,C andE showtheresponse
to 40 and 80μm glycine in control solution. For each
dose of antagonist, glycine concentrations were chosen
in order to elicit currents similar in amplitude to those
recordedincontrolsolution(righttracesinFig.2A,C and
E). The partial dose–response curves for glycine with and
withoutSR-95531weresimultaneouslyﬁttedwithapower
function and constrained to be parallel, as shown in the
log–log plots of Fig.2B, D and F for each concentration
of antagonist. The average values of r−1 were plotted
on a log–log scale versus the concentration of antagonist
(Fig.2G,wherethenumberofcellsisindicatedaboveeach
point) and ﬁtted with a power function (see Methods).
The value of the slope was 1.02±0.08, conﬁrming the
competitive nature of the antagonist. Data were re-ﬁtted
with the slope constrained to 1 and this gave a value ofKB
of 191±8μm. In a minority of cells (n=4), we obtained
twodoseratios(i.e.for100and500μmSR-95531).These
experiments gave four independent Schild plots, with
a slope of 1.01±0.04 and a KB of 190±10μm (data
not shown), these values were not different from those
obtained from pooled data.
The Schild plot is a null method and because of that,
it gives a correct estimate of KB for a very wide class of
models (Colquhoun, 1973).
The KB value we estimated is clearly high, but low
afﬁnity is not necessarily due only to fast unbinding. In
order to check that in this case it is, we preincubated
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our patches with 1mm SR-95531; according to our KB
estimate of 191μm, that should give a 99.6% occupancy
of antagonist bound states. This occupancy is calculated
from the equation:
Occupancy = 1 −
1
 
1 +
[B]
KB
 3
where [B] is the antagonist concentration. The equation
assumes there are three identical and independent
antagonist binding sites.
We then performed fast applications of 3mm glycine (3
or 200ms pulses) at the same time as the antagonist was
washed out (Fig.3). If antagonist unbinding is fast, the
glycine response should have a slower rise time, but reach
a peak similar to that observed in control.
Figure3A shows responses to a 200ms glycine pulse
in control (black) and after preincubation with SR-95531
(grey):clearlytheshapeoftheresponseisbarelychangedin
thatthedesensitizedphaseisdescribedbytwoexponentials
with time constant and amplitude of τ1 =16±2ms
(66±16%) and τ2 =129±36ms (34±16%; n=5, not
signiﬁcantly different from the control values). For short
(3ms) glycine pulses, the deactivation time course of
responses did not change either, and was ﬁtted with two
exponential components of time constant and amplitude
Figure 2. Schild analysis of the effect of co-application of SR-95531 (100, 300 and 500 μm) on whole-cell
responses to glycine
A, C and E, show inward currents in response to approximately equipotent glycine concentrations with and without
three different concentrations of antagonist. B, D and F, show the shifts in the glycine dose–response curves
produced by these three antagonist concentrations and are the ﬁts of two power functions (with the constraint
of equal slopes) to the peak currents measured in each experiment. For each antagonist concentration the dose
ratio (r) was calculated as the distance between the two parallel lines. G, the Schild plot uses the average dose
ratio values from all recordings (plotted on a log–log scale versus the antagonist concentrations). The ﬁt to the
Schild equation (slope constrained to one) gave a value of equilibrium dissociation constant (KB) of 191 ± 8 μM
(the number of cells at each concentration is indicated above each point).
τ1 =8±1ms (53±6%) and τ2 =47±9 (47±9%;
n=6, data not shown). On the other hand, the response
rise time (shown on an expanded timescale in Fig.3B)
increased from 140±20μs in control to 640±110μs
following preincubation with the antagonist (n=11,
data pooled from 3 and 200ms applications). The peak
amplitudeofglycineresponsesinthepresenceofSR-95531
was, however, only slightly reduced to 90±1% (n=6,
200ms steps) or 92±2% (3ms steps, see histogram of
Fig.3F). This indicates that receptors that were bound to
the antagonist become rapidly available during SR-95531
washout on a timescale of milliseconds. We ﬁtted the
rise time of the response after antagonist preincubation
using a classical competitive mechanism (Fig.4D), which
postulates that there are three equal and independent
binding sites for SR-95331 and that any state bound to
the antagonist cannot open.
T h ep r o t o c o li nF i g .3 A can give information only on
the unbinding rate of SR-95531 (koffSR), so initially we
ﬁtted the rise time of the response ﬁxing all the binding,
gating and desensitization rates to the optimized values
of Fig.1G. The ﬁt is not sensitive to variations in the
association rate constant of the antagonist, konSR and we
constrained it to give a value of KB of 200μm (within
the range of our estimate from the whole cell experiments
in ﬁg.2). The data together with the ﬁt are shown on an
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expanded timescale in Fig.3C and gave an average value
for koffSR of 3158s−1 ±10% (n=11). Hence the mean
lifetime of an occupancy by the antagonist is of the order
of 300μs.
Our estimate of koffSR relies on the observation that
SR-95531actsasapurelycompetitiveantagonist,asshown
by Wang & Slaughter (2005) and conﬁrmed by our Schild
analysis (Fig.2), and on the assumptions of the kinetic
model used to describe glycine currents in control. In
order to test how robust this estimate is to the initial
assumptions that we used to describe our control data, we
re-ﬁtted the rise time of the responses to 200ms glycine
pulsesﬁxingthegatingrateconstantstomuchlowervalues
than the ones we determined from our single-channel
analysis (Burzomato et al. 2004). We now constrained
β and α to 5000 and 500s−1, respectively (i.e. 25- and
12-fold lower than the rates we used before). These values
are in the range of those chosen by Gentet & Clements
(2002)toﬁttheirdata.Re-ﬁttingthevaluesofthebinding
rates for glycine and for SR-95531 with this constraint
Figure 3. The offset and onset of SR-95531 antagonism
A, shows the responses to 200 ms applications of 3 mM glycine with (grey trace) and without (black trace)
pre-equilibration with SR-95531. The onset of desensitization is very similar in the two experimental conditions. B,
the rise time of the current response is approximately 3-fold slower after pre-equilibration with SR-95531 (compare
grey and black traces in). This is due to the progressive increase of available receptors as the antagonist washes
out. C, shows the simultaneous ﬁt of the rise time of the responses (with and without antagonist) to the model of
Fig. 4D with only the unbinding rate of SR-95531 (koffSR) as a free variable and the association rate constant konSR
constrained to give a value of equilibrium dissociation constant (KB)o f2 0 0μM. D, shows the response to 40 μM
glycine (average of 50 individual traces). Once a steady level of current in response to glycine was reached, 288 μM
SR-95531 was co-applied with glycine (see bars below the traces). Note that because of the technical limitations
of the theta tube application (i.e. the number of barrels available), the onset of glycine application was obtained
by manually switching on glycine perfusion, whereas the transition to glycine + antagonist is a true concentration
jump. The current decreased to 15% of its control value and the onset of the antagonist effect was ﬁtted to the
model of Fig. 4D with konSR as the only free variable. E, the ﬁt (black line) is shown on an expanded timescale
superimposed on the data (grey trace). F, histogram shows the percentage reduction in the peak current elicited
by 200 ms or 3 ms steps to 3 mM glycine after pre-equilibration with 1 mM SR-95531 and the reduction induced
by 288 μM SR-95531 co-applied with 40 μM glycine.
on the gating rates, gave a kon estimate 4-fold higher
(22.4×106 s−1 μm−1 ±21%) that accounted for the fast
observed rise time of glycine-induced currents. The value
obtainedforkoffSRfromthepreincubationexperimentswas
2950s−1 ±13% (n=5; not signiﬁcantly different from
that obtained earlier, paired t test,P=0.35).
The effect of an antagonist will follow the Schild
equation only if there is true competition between
agonist and antagonist at each binding site (Colquhoun,
1973). Thus the results of our Schild analysis imply that
glycine and SR-95531 share the same binding sites. Note,
however, that the effect of SR-95531 on macroscopic
GABAA responses has also been successfully described by
a model with two binding sites for agonist and one for
the antagonist (Jones et al. 1998, 2001). Therefore we
attempted to ﬁt the data of Fig.3A to models that had
one or two binding sites for the antagonist (but retained
three binding sites for glycine). Fits with a single binding
site for SR-95531 were not in good agreement with the
data: the estimated koffSR was 1950s−1 ±17% (n=5), but
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thenormalizedsquaredifferencebetweenthedataandthe
ﬁt was signiﬁcantly worse than that for the ﬁts with three
binding sites (paired t test, P >0.05). However, allowing
fortwoantagonistbindingsitesgaveagooddescriptionof
the data with an average koffSR of 3973s−1 ±36% (n=5)
andthenormalizedsquaredifferencewasnotsigniﬁcantly
differentfromthatobtainedformodelswiththreebinding
sites (P =0.16). This conﬁrms that ﬁtting macroscopic
currentstokineticschemesdoesnotallowanunequivocal
distinctionbetweentwoorthreebindingsitesforboththe
agonist and the antagonist. However, the observation that
theslopeoftheSchildplotisveryclosetoonerulesoutany
modelinwhichtheagonistandantagonistdonotcompete
for the same number of sites.
An independent estimate of konSR was obtained by
applyingantagonistduringalongapplicationofglycine.A
low concentration of glycine (40μm) was chosen in order
to minimize the occupancy of desensitized states. When
the response reached a steady state, a solution containing
288μm SR-95531 and 40μm glycine was applied through
thethetatube(Fig.3D).Theonsetoftheantagonistaction
was ﬁtted, ﬁxing all the rate constants (including koffSR)t o
thepreviouslyoptimizedvaluesandleavingonlykonSR asa
freeparameter.Thecurrentdeclinedto15±2%ofcontrol
values(Fig.3F)andtheﬁttedcurvewasingoodagreement
with the data (see the expanded trace in Fig.3E). The
average estimate for konSR was 1.8×107 s−1 μm−1 ±13%
(n=5). Together with our estimate of koffSR (see above),
Figure 4. Inhibition of responses to short glycine pulses by equilibrium application of SR-95531
A and B, show two examples of responses to 3 mM glycine before (black trace) and during (grey trace) steady-state
application of 288 μM antagonist. There is a consistent increase in the rise time of the response (see insets), but
the percentage inhibition of the peak is different in the two cases. This is correlated with the actual length of
the glycine concentration pulse, which is shorter in A (∼1 ms) than in B (∼1.6 ms). C, this is shown for seven
experiments in which the actual length of the pulse was plotted against the percentage reduction of peak current
in the presence of SR-95531 ( ). The prediction of the response to square pulses of glycine of variable duration
are shown in the same graph (; joined by cubic splines for clarity). D, gives a summary of the values of the rate
constants ﬁtted from the different experimental protocols.
thisgivesavalueforKB of175μm,whichissimilartothat
obtained from the Schild analysis (191μm).
We then tested the effect of steady-state application
of SR-95531 on the response to very short pulses of
saturatingglycine(i.e.theprotocolthatbestapproximates
the behaviour of channels at a synapse). The rise time
of the response to glycine in the continuous presence of
288μmSR-95531(aconcentrationatwhich,givenaKB of
175μm, only 5% of the channels should be available) was
consistently slowed from 190±4t o6 2 0±20μs( n=7).
It was somewhat surprising to ﬁnd that the reduction in
peak amplitude was quite variable and ranged from 30%
to 90% of control (average value, 65±8%) as shown by
theexamplesinFig.4A(50%inhibition)andFig.4B(30%
inhibition) where responses in control (black) are super-
imposed on those in the presence of SR-95531 (grey).
However, measuring the open tip potential at the end
of each experiment showed that the actual concentration
proﬁles produced delivering a 1ms voltage step to the
piezo-translatordidvaryconsiderablyfrompatchtopatch.
FortheexamplesinFig.4AandB,thetruehalf-widthofthe
glycine application was 0.98 (inset of Fig.4A) and 1.68ms
(inset of Fig.4B). We therefore calculated how the peak
response to pulses of glycine is expected to vary in the
presence of antagonist as a function of pulse length. The
values expected from the rates of the model in Fig.4D
at selected pulse durations are plotted as percentage of
control as black squares in Fig.4C. The grey dots are
C   2007 The Authors. Journal compilation C   2007 The Physiological Society178 M. Beato and others J Physiol 580.1
the observed values (n=7 experiments). As expected,
there is a strong correlation between the actual pulse
duration and the amount of inhibition. The calculated
points systematically underestimate the antagonist effect,
probably because they are calculated for an ideal square
pulse, whereas the glycine concentration at the patch
is likely to rise more slowly. This could increase the
contributionofdesensitizedstatesandreducetheobserved
amplitude.
Discussion
Our data show that the low-afﬁnity competitive
antagonistSR-95531(Wang&Slaughter,2005)dissociates
from heteromeric α1β glycine receptors at a rate of
approximately 3000s−1: this means that, in a fraction
of a millisecond (a time comparable to the postulated
lifetime of the transmitter at the synapse), the antagonist
can unbind from a sizeable proportion of the channels it
occupiedinitially.Withthisrateofunbinding,theamount
of inhibition induced by the antagonist is expected to
be inversely proportional both to the concentration of
glycine and to the time glycine is present in the cleft. This
predictionisconﬁrmedbytheobservationthattheamount
of inhibition induced by a subsaturating concentration of
the antagonist decreases as the length of the glycine pulse
is increased.
Measurement of the association and dissociation
rates for competitive antagonists has long been a
goal for pharmacologists (Hill, 1909; Jenkinson, 1960;
Colquhoun, 1981), but the limits on the speed of
solution exchange, and lack of voltage dependence,
made this impossible for all but the slowest antagonists,
until the recent advent of fast-application techniques
(Clements et al. 1992; Wenningmann & Dilger, 2001).
Unbinding rates for high-afﬁnity antagonists, such
as the NMDA receptor antagonists 3-((r)-2-carboxy-
piperazin-4-yl)-propyl-1-phosphonic acid (d-CPP) and
and d-(–)-2-aminophosphonopentanoic acid (d-AP5)
are relatively slow (up to 20s−1), and can therefore
be measured in experiments on whole cells, where
concentration changes are achieved in about 10ms
(Benveniste & Mayer, 1991). The faster unbinding rates
of low-afﬁnity antagonists require faster applications,
which are possible only on outside-out patches. Examples
range from 160s−1 for d-aminoadipate on NMDA
receptors (Clements et al. 1992) to 1700s−1 for
(1,2,5,6-tetrahydropyridine-4-yl)-methylphosphinic acid
(TPMPA) on GABAA receptors (Joneset al. 2001). Clearly
the dissociation rate for SR-95531 from glycine receptors
is greater than this at 3000s−1.
In our analysis we have described receptor activation
by as simple as possible a model, using three sequential
bindingstepsandonefullyligandedopenstate.Thismodel
describes adequately the features of macroscopic glycine
responses in their desensitization (Fig.1B), deactivation
(Fig.1E) and rise time (Fig.1C and F). The main
features of the model (Fig.4D) for the antagonist are the
assumption that occupancy of the receptor by a single
molecule of antagonist is sufﬁcient to prevent opening
and that binding of antagonist and agonist are mutually
exclusive.
The activation model ﬁtted here differs from the
mechanisms that we found were best at describing
steady-state glycine receptor single-channel activity (ﬂip
(Burzomato et al. 2004) and a modiﬁed Jones &
Westbrook-type mechanism (Jones & Westbrook, 1995).
No mechanistic signiﬁcance should be attached to that –
the poor resolution of the macroscopic technique means
that it is not realistic to ﬁt to these data mechanisms that
include detailed description of partially liganded states.
In addition to that, any model that aims to describe
responses to the concentration jumps performed here
mustincludedesensitizedstatesthatareexplicitlyexcluded
from single-channel analysis because of the division of
the data into clusters. We nevertheless found that our
estimatesofthebindingratesforSR-95531wereunaffected
by changes in the details of the mechanism, such as the
values to which glycine gating rates were constrained.
The use of the competitive antagonist method on an
isolated glycinergic synaptic input will provide a powerful
tool to assess the concentration of glycine in the cleft
following spike-induced release and could clarify one of
the main presynaptic determinants of synaptic strength.
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